8.02
Finanzdaten der Maplight Therapeutics Inc-Aktie (MPLT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
1.48%
63.55
|
64.50 | 83.38 | 31.50 |
| Operating Income/Loss |
1.48%
-63.55
|
-64.50 | -83.38 | -31.50 |
| Net Income/Loss |
0.78%
-60.19
|
-60.67 | -79.55 | -29.42 |
| Basic Average Shares |
0.34%
45.43
|
45.28 | - | 0.7911 |
| Diluted Average Shares |
0.34%
45.43
|
45.28 | - | 0.7911 |
| Basic Earnings Per Share |
1.49%
-1.32
|
-1.34 | - | -37.18 |
| Diluted Earnings Per Share |
1.49%
-1.32
|
-1.34 | - | -37.18 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):